anmelden
FTSE All-Share
5.487,27
PKT
-33,68
PKT
-0,61
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu FTSE All-Share-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 04.04.24 | BP Outperform | RBC Capital Markets | |
| 04.04.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 03.04.24 | GSK Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.24 | Shell (ex Royal Dutch Shell) Buy | Jefferies & Company Inc. | |
| 03.04.24 | BP Buy | Jefferies & Company Inc. | |
| 03.04.24 | Vodafone Group Underperform | Bernstein Research | |
| 02.04.24 | Unilever Overweight | Barclays Capital | |
| 02.04.24 | Barclays Buy | Jefferies & Company Inc. | |
| 28.03.24 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 28.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 28.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 27.03.24 | Rio Tinto Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.24 | Vodafone Group Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.24 | HSBC Equal Weight | Barclays Capital | |
| 25.03.24 | Rio Tinto Buy | Deutsche Bank AG | |
| 25.03.24 | AstraZeneca Sell | UBS AG | |
| 25.03.24 | HSBC Neutral | UBS AG | |
| 25.03.24 | Unilever Sell | UBS AG | |
| 20.03.24 | GSK Buy | Jefferies & Company Inc. | |
| 19.03.24 | Unilever Underperform | Jefferies & Company Inc. | |
| 19.03.24 | Unilever Underweight | JP Morgan Chase & Co. | |
| 19.03.24 | Unilever Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.03.24 | Unilever Sell | UBS AG | |
| 19.03.24 | Unilever Overweight | Barclays Capital | |
| 19.03.24 | Vodafone Group Equal Weight | Barclays Capital | |
| 19.03.24 | Unilever Market-Perform | Bernstein Research | |
| 19.03.24 | Diageo Outperform | Bernstein Research | |
| 19.03.24 | AstraZeneca Sell | UBS AG | |
| 19.03.24 | Unilever Sector Perform | RBC Capital Markets | |
| 19.03.24 | GSK Buy | UBS AG | |
| 18.03.24 | Shell (ex Royal Dutch Shell) Overweight | Barclays Capital | |
| 18.03.24 | GSK Underweight | JP Morgan Chase & Co. | |
| 18.03.24 | BAT Neutral | Goldman Sachs Group Inc. | |
| 15.03.24 | Vodafone Group Buy | UBS AG | |
| 15.03.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 15.03.24 | Glencore Outperform | RBC Capital Markets | |
| 15.03.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 14.03.24 | Shell (ex Royal Dutch Shell) Neutral | UBS AG | |
| 14.03.24 | BP Buy | UBS AG | |
| 14.03.24 | BAT Neutral | UBS AG |